Evolus has filed material events (8-K filings) dated May 4 and June 12, 2026, likely signaling pricing or loyalty program changes for Jeuveau (prabotulinumtoxinA) and the Evolus Rewards program. Evolus has built its medspa market share through aggressive pricing and rebate incentives; any material change could indicate either competitive pressure or strategic repositioning.